Seelaus Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$795K Buy
663
+4
+0.6% +$4.09K 0.56% 41
2026
Q1
$566K Buy
659
+226
+52% +$229K 0.41% 67
2025
Q4
$465K Hold
433
0.37% 80
2025
Q3
$330K Sell
433
-10
-2% -$7.44K 0.26% 112
2025
Q2
$345K Hold
443
0.31% 100
2025
Q1
$366K Sell
443
-18
-4% -$15K 0.35% 90
2024
Q4
$356K Hold
461
0.32% 100
2024
Q3
$408K Sell
461
-4
-0.9% -$3.6K 0.37% 86
2024
Q2
$421K Hold
465
0.43% 75
2024
Q1
$362K Sell
465
-426
-48% -$303K 0.36% 92
2023
Q4
$519K Buy
891
+245
+38% +$143K 0.51% 65
2023
Q3
$347K Sell
646
-1,898
-75% -$978K 0.39% 89
2023
Q2
$1.19M Sell
2,544
-1,474
-37% -$618K 0.94% 24
2023
Q1
$1.49M Buy
4,018
+293
+8% +$98.8K 1.12% 18
2022
Q4
$1.36M Hold
3,725
1.02% 22
2022
Q3
$1.2M Buy
3,725
+162
+5% +$51.3K 0.96% 26
2022
Q2
$1.16M Buy
+3,563
New +$1.07M 0.86% 28

Other funds holding LLY

Seelaus Asset Management's LLY Position: Q2 2026 in Review

Seelaus Asset Management increased its Eli Lilly (LLY) stake by 0.61% in Q2 2026, buying an estimated $4.09K and bringing the position to 663 shares worth $795K. The position accounts for 0.56% of the portfolio, ranked #41.

Seelaus Asset Management first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.49M in Q1 2023. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Seelaus Asset Management held 663 shares of Eli Lilly worth $795K as of Q2 2026.
  • Seelaus Asset Management bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.56% of Seelaus Asset Management's portfolio in Q2 2026, its #41 holding.
  • Seelaus Asset Management first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • Seelaus Asset Management's Eli Lilly position peaked at $1.49M in Q1 2023.
  • 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.